Mandate

Bravida listed on Nasdaq Stockholm

October 22, 2015

Bravida Holding AB (publ) has on 16 October 2015 been admitted to trading on Nasdaq Stockholm. The price in the offering was set at SEK 40 per share, corresponding to a market value of all shares issued by Bravida of SEK 8.1 billion. The offer, which consisted of an offer to the general public in Sweden and an international offer to institutional investors, comprised in total 40.5 percent of the Bravida shares offered by Bravissima Holding AB, Bravida´s principal owner, which is indirectly controlled by certain investment funds advised by Bain Capital, LLC and affiliated parties. The total value of the offering amounts to SEK 3.2 billion, assuming that the over-allotment option is exercised in full.

Bravida is a leading provider of multi-technical services within electricity, heating and plumbing as well as ventilation and air conditioning in the Nordic region. With 237 branches across 140 locations, Bravida offers installation and services solutions throughout the Nordic region with strong local presence. For the year ended 31 December 2014, Bravida recorded net sales of SEK 12 billion.

Bravida and Bravissima Holding AB were advised by Vinge in connection with the listing and Vinge’s team mainly consisted of Charlotte Levin, Christina Kokko, Louise Brorsson Salomon, Nicolina Kindblom, Rikard Lindahl, Nils Fredrik Dehlin, Emelie Klefbeck, Filip Öhrner, Linn Adelwald and Samra Baytar. Further, Odile Fallenius, Maria Schultzberg and Tora Hansjons have assisted with tax related matters.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025